Fidelity Investments’s ESSA Pharma EPIX Stock Holding History

Fidelity Investments’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-597,650	Closed	-$8.49M	–	5095
2021 Q4	$8.49M	Buy	597,650 +110,247	+23%	+$1.23M	﹤0.01%	2175
2021 Q3	$3.9M	Sell	487,403 -309,800	-39%	-$4.93M	﹤0.01%	2424
2021 Q2	$22.8M	Hold	797,203	–	–	﹤0.01%	1793
2021 Q1	$23.2M	Buy	+797,203	New	+$18.5M	﹤0.01%	1741

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments's EPIX Position: Q1 2022 in Review

Fidelity Investments sold out of ESSA Pharma (EPIX) in Q1 2022, closing a stake of 597,650 shares — an estimated $8.49M sold.

Fidelity Investments first reported a position in EPIX in Q1 2021 and held it in 4 quarters. The position peaked at $23.2M in Q1 2021. 70 funds tracked by Wall St. Rank hold EPIX as of Q1 2022.

Fidelity Investments reported no remaining ESSA Pharma position as of Q1 2022 after selling out during the quarter.
Fidelity Investments sold 597,650 ESSA Pharma shares in Q1 2022, an estimated $8.49M.
Fidelity Investments first reported a position in ESSA Pharma in Q1 2021 and held it in 4 quarters.
Fidelity Investments's ESSA Pharma position peaked at $23.2M in Q1 2021.
70 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2022.

Based on Fidelity Investments's 13F filing for Q1 2022, filed 13 May 2022.